MassScreening

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses work on lung cancer screening, the features of a pulmonary nodule that raise and lower suspicion for lung cancer, and other aspects of initial and follow-up imaging for lung cancer.</span></p>  

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses work on lung cancer screening, the features of a pulmonary nodule that raise and lower suspicion for lung cancer, and other aspects of initial and follow-up imaging for lung cancer.</span></p>  

Full Field Digital Mammography Systems are being evaluated for use in the NHS Breast Screening Programme in the UK. As part of this evaluation, the different companies were invited to take part in a comprehensive evaluation of the mammography units, including medical physics and radiographic aspects. Swedish Company, SECTRA (www.sectra.se/medical) are one of the major companies who have had their equipment evaluated for the NHS Breast Screening Programme in the UK. Released as publication 0601, a PDF is available both on the RCRBG website (members section) and the NHSBSP website (cancerscreening.org.uk) I interviewed Matt Wallis at the recent Royal College of Radiologists Breast Group Annual Scientific Meeting in Edinburgh about the NHSBSP Evaluation of the SECTRA Microdose FFDM equipment in a mobile van at Coventry and Warwickshire Hospital. © Dr Chris Flowers Nov 2006  

Full Field Digital Mammography Systems are being evaluated for use in the NHS Breast Screening Programme in the UK. As part of this evaluation, the different companies were invited to take part in a comprehensive evaluation of the mammography units, including medical physics and radiographic aspects These however, have not yet included Mammo RIS/interface with hospital PACS systems or workstations Swedish Company SECTRA (www.sectra.se/medical) are one of the major companies who have approached all aspects of the digital process and have a vendor neutral workstation and a Mammo PACS system I interviewed Neil Emery at the recent Royal College of Radiologists Breast Group Annual Scientific Meeting in Edinburgh about their Digital Solutio © Dr Chris Flowers Nov 2006  

A Series of audiocasts from the Royal College of Radiologists Breast Group. Exploration of Digital Mammography, The DMIST study, and implementation in both screening services and the hospital setting. Applicable to radiologists in Western countries.  

This video consists of two short films, addressing 1) the ethics of screening programes, and 2) the moral and legal issues associated with treating asylum seekers in the NHS. Alex Presland & Aliya Bryce  

The second script for the video, 'Ethics of Screening Programmes and Treating Asylum Seekers'; specifically, for the 'Aches and Pains' film, which addresses the implications of treating asylum seekers in the NHS. Alex Presland & Aliya Bryce  

The first script for the video, 'Ethics of Screening Programmes and Treating Asylum Seekers'; specifically, for the Jeremy Kyle film, which focusses on the ethical issues of screening programmes. Alex Presland & Aliya Bryce  

Evidence based population health screening  

The ability to carry out a thorough and slick GALS exam is something every medic needs to master. This video aims to give you an idea of what's required in the OSCE and you can then customise the examination to suit your own personal style. Make sure to head over to http://geekymedics.com/osce/gals-assessment/ to see the written guide alongside the video. Like us on Facebook http://www.facebook.com/geekymedics Follow us on twitter at http://www.twitter.com/geekymedics Contact us at geekymedics@gmail.com with any questions or feedback. Always refer to your local medical school / hospital guidance before applying any of the steps demonstrated in this video guide.  

Tutorial on evaluating for signs of autism in toddlers, produced by Help Autism Now Society.  

PaediatricScreening Condition Who? How? Why? What next? Rubella Pregnant Women Blood test Un-immune women,if become exposed theychildmaydevelopFoetal Rubella S…  

Stream Twenty-five Year Follow-up of the Canadian National Breast Screening Study by BMJ talk medicine from desktop or your mobile device  

Much of the follow-up of pregnant women is carried out in the community, by midwifes at primary health care centres. The risk of death from pregnancy in the UK is roughly 1 in 20 000. Antenatal care is as much about educating women about pregnancy, childbirth and child care, as it is about providing for actual medical needs, particularly in the case of a first pregnancy. The exact measures will differ between NHS trusts, but below is a general outline of the type of care provided in pregnancy.    

Stream Who, when and how: Screening for MRSA by BMJ talk medicine from desktop or your mobile device  

Lung cancer is a health problem that clearly merits a screening programme. Each year about 35 000 people in the United Kingdom die from lung cancer—more than the number for colorectal and breast cancer combined. In addition, about three quarters of people present with incurable disease, at a stage when treatment has little effect on overall survival; early stage disease is curable; risk factors for lung cancer are well understood; and a highly sensitive screening test is available.  

Objectives To review, summarise, and compare the evidence for effectiveness of screening sigmoidoscopy and screening colonoscopy in the prevention of colorectal cancer occurrence and deaths.  

Few healthcare issues have generated as much controversy as prostate specific antigen (PSA) based screening for prostate cancer.1 2 Enthusiasm for such screening is high in part because a seemingly simple blood test can lead to early detection and treatment of a common and potentially lethal disease. Screening has resulted in a noticeable increase in incidence of prostate cancer and near universal active treatment for screen detected disease. However, recent science shows that screening for prostate cancer, as with all screening strategies, is a complex process and double-edged sword. This provides the background for the linked paper by Carlsson and colleagues (doi:10.1136/bmj.g2296).3 Though some men may benefit from screening, many more are harmed by testing and the cascade of diagnostic and treatment related events that follow. Further, men and society bear the financial costs of this screening cascade.  

Objectives To review, summarise, and compare the evidence for effectiveness of screening sigmoidoscopy and screening colonoscopy in the prevention of colorectal cancer occurrence and deaths.